Ovarian Suppression in the Management of Premenopausal Breast Cancer: Methods and Efficacy in Adjuvant and Metastatic Settings

Publisher： Karger

E-ISSN： 1423-0232|75|3-4|192-202

ISSN： 0030-2414

Source： Oncology, Vol.75, Iss.3-4, 2008-10, pp. : 192-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian function suppression is beneficial in some premenopausal women with early breast cancer

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 66, Iss. 5, 2016-09 ,pp. : 355-356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

Adjuvant endocrine therapy of premenopausal women with early breast cancer: an overview

By Hubalek Michael  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 167-173

Springer Publishing Company

Access to resources Recommend Favorite

Hereditary Premenopausal Breast Cancer

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Surgical management of ovarian carcinoma metastatic to the breast and axilla: A role for metastasectomy?

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 581-584

John Wiley & Sons Inc

Access to resources Recommend Favorite